Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
08/2005
08/25/2005CA2553700A1 Hydrogenation method for producing optically active alcohols or carboxylic acids
08/25/2005CA2553249A1 Method for producing optically active alcohols or carboxylic acids
08/24/2005EP1566212A1 Apparatus for the cooling of hot reaction gases, e.g. for the preparation of phthalic anhydride
08/24/2005EP1565457A2 Process for synthesis bis-aryl diamidoxime compounds
08/24/2005EP1565438A1 Antitumor benzoylsulfonamides
08/24/2005EP1565190A2 Arylcyclopropylcarboxylic amides as potassium channel openers
08/24/2005EP1420761A4 Solid phase syntheis of salts of organic acid
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1317413B1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659133A 2, 5-bis-diamine-[1, 4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor
08/24/2005CN1658970A Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst
08/24/2005CN1216436C Nonaqueous electrolytic solution and secondary battery containing the same
08/24/2005CN1216050C 5,6,7-trinor -4,8-inter-m-phenylene PGI2 derivative and drugs containing the same
08/24/2005CN1216049C Process for preparation of citalopram
08/24/2005CN1216030C O-acyl-alpha-hydroxycarboxylic ester compounds and their preparation method
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6934639 Using the three-dimensional structure of human collagenase-3 (MMP-13), a member of the matrix metalloproteinase (MMP) for drug design of MMP-13 inhibitors
08/23/2005US6933412 Low loss high refractive index vinyl sulfide compounds and method of making same
08/23/2005US6933317 PGD2 receptor antagonistic pharmaceutical compositions
08/23/2005US6933307 Fungicidal phenylimine derivatives
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/23/2005CA2292132C Benzylidene-.gamma.-butyrolactones, process for their preparation and their use as uv absorber
08/23/2005CA2153235C Compounds having selectivity for retinoid x receptors
08/18/2005WO2005075455A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005WO2005075452A1 2-halofuryl/thienyl-3-carboxamides
08/18/2005WO2005075447A1 Crystalline polymorphs of a cxc-chemokine receptor ligand
08/18/2005WO2005075446A1 Unsaturated carboxylic acid hemiacetal ester, polymer, and resin composition for photoresist
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005074389A2 Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds
08/18/2005US20050182238 Method for producing polytetrahydrofurane having a low color indices
08/18/2005US20050182127 Broad activity spectrum against both endo- and ectoparasites in and on warm-blooded animals and plants; antihelmintics; nematocides
08/18/2005US20050182121 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use
08/18/2005US20050182081 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
08/18/2005US20050179013 Hyperpolarizable organic chromophores
08/18/2005DE102004005106A1 New furanone and bicyclooctane derivatives, e.g. sorbifuranone A, B or C, sorbivinetone and sorbivinetol, useful as antitumor agents, prepared e.g. by culturing Penicillium fungi
08/18/2005CA2720312A1 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005CA2556081A1 2-halofuryl/thienyl-3-carboxamides
08/18/2005CA2555453A1 Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1562930A2 Synthetic lactone formulations and method of use
08/17/2005EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562922A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562911A1 Compositions useful as inhibitors of jak and other protein kinases
08/17/2005EP1562903A2 Mucin synthesis inhibitors
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP1204628B1 Method for producing phthalic anhydride according to specifications
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005CN1656237A Antiviral inhibition of capsid proteins
08/17/2005CN1656146A Method for producing polytetrahydrofurane having a low color indices
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/17/2005CN1656087A Therapeutic ion channel blocking agents and methods of use thereof
08/17/2005CN1656086A Benzofuran derivative
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1653924A Warm deteriorating suppressing method for tea beverage and tea beverage
08/17/2005CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/16/2005US6930211 Production methods of citalopram and intermediates therefor
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/11/2005WO2005073205A1 Selective estrogen receptor modulators
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005072711A2 Method for producing sorbicillactone a
08/11/2005WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
08/11/2005WO2005026141A3 Process for preparation of substituted butenolides via palladium-free etherification and amination of masked mucohalic acids
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2005007635A3 Combretastatin derivatives with cytotoxic action
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176974 Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran
08/11/2005US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation
08/11/2005US20050176814 mono- or polydeuterated 4-(p-Methylsulfonylphenyl]-3-phenyl-2-(5H)-furanones; degenerative joint disorders, acute pain and primary dysmenorrhea
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176805 Novel compounds for treatment of cardiac arrhythmia, synthesis, and methods of use
08/11/2005US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis
08/11/2005US20050176788 Such as 2-[N-(4,5-dimethoxy-2-hydroxybenzoyl)amino]-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole; compounds relax gastric fundus, to relieve feeling of early satiety and bloating; gastrointestinal motility disorders
08/11/2005US20050176779 dioxodihydropyridine derivatives and certain methacrylic acid and furan derivative precursors thereof; use as tumor growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005CA2554733A1 Method for producing sorbicillactone a
08/11/2005CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/10/2005EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560810A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
08/10/2005EP1515956A4 Peptide deformylase inhibitors
08/10/2005EP1478637B1 Amorphous citalopram salts
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP0968158B1 Method of preparing substituted indanones, the substituted indanones and metallocenes prepared therefrom
08/10/2005CN1653057A Manufacture of ascorbic acid esters
08/10/2005CN1653056A Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653028A Liquid phase oxidation of halogenated ortho-xylenes